Pfizer Statistics
Share Statistics
Pfizer has 5.67B
shares outstanding. The number of shares has increased by 0.09%
in one year.
| Shares Outstanding | 5.67B |
| Shares Change (YoY) | 0.09% |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | 65.91% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 7,096 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 107.43M, so 1.9% of the outstanding
shares have been sold short.
| Short Interest | 107.43M |
| Short % of Shares Out | 1.9% |
| Short % of Float | 1.9% |
| Short Ratio (days to cover) | 1.63 |
Valuation Ratios
The PE ratio is 18.71 and the forward
PE ratio is 7.87.
Pfizer's PEG ratio is
0.07.
| PE Ratio | 18.71 |
| Forward PE | 7.87 |
| PS Ratio | 2.36 |
| Forward PS | 2.4 |
| PB Ratio | 1.7 |
| P/FCF Ratio | 15.28 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Pfizer has an Enterprise Value (EV) of 212.87B.
| EV / Sales | 3.35 |
| EV / EBITDA | 11.74 |
| EV / EBIT | 16.7 |
| EV / FCF | 21.64 |
Financial Position
The company has a current ratio of 1.17,
with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.17 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 3.51 |
| Debt / FCF | 6.47 |
| Interest Coverage | 4.83 |
Financial Efficiency
Return on Equity is 9.11% and Return on Invested Capital is 8.45%.
| Return on Equity | 9.11% |
| Return on Assets | 3.76% |
| Return on Invested Capital | 8.45% |
| Revenue Per Employee | $785,518.52 |
| Profits Per Employee | $99,148.15 |
| Employee Count | 81,000 |
| Asset Turnover | 0.3 |
| Inventory Turnover | 1.51 |
Taxes
| Income Tax | -28M |
| Effective Tax Rate | -0.35% |
Stock Price Statistics
The stock price has increased by -13.02% in the
last 52 weeks. The beta is 0.6, so Pfizer's
price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -13.02% |
| 50-Day Moving Average | 24.61 |
| 200-Day Moving Average | 26.94 |
| Relative Strength Index (RSI) | 56.35 |
| Average Volume (20 Days) | 52,634,438 |
Income Statement
In the last 12 months, Pfizer had revenue of 63.63B
and earned 8.03B
in profits. Earnings per share was 1.42.
| Revenue | 63.63B |
| Gross Profit | 47.21B |
| Operating Income | 14.94B |
| Net Income | 8.03B |
| EBITDA | 18.13B |
| EBIT | 11.11B |
| Earnings Per Share (EPS) | 1.42 |
Full Income StatementBalance Sheet
The company has 1.04B in cash and 63.65B in
debt, giving a net cash position of -62.61B.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 63.65B |
| Net Cash | -62.61B |
| Retained Earnings | 116.72B |
| Total Assets | 213.4B |
| Working Capital | 7.36B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 12.74B
and capital expenditures -2.91B, giving a free cash flow of 9.84B.
| Operating Cash Flow | 12.74B |
| Capital Expenditures | -2.91B |
| Free Cash Flow | 9.84B |
| FCF Per Share | 1.74 |
Full Cash Flow StatementMargins
Gross margin is 74.19%, with operating and profit margins of 23.48% and 12.62%.
| Gross Margin | 74.19% |
| Operating Margin | 23.48% |
| Pretax Margin | 12.61% |
| Profit Margin | 12.62% |
| EBITDA Margin | 28.49% |
| EBIT Margin | 23.48% |
| FCF Margin | 15.46% |
Dividends & Yields
PFE pays an annual dividend of $2.12,
which amounts to a dividend yield of 7.1%.
| Dividend Per Share | $2.12 |
| Dividend Yield | 7.1% |
| Dividend Growth (YoY) | 2.38% |
| Payout Ratio | 153.62% |
| Earnings Yield | 5.34% |
| FCF Yield | 6.55% |
Dividend DetailsAnalyst Forecast
The average price target for PFE is $29.5,
which is 22% higher than the current price. The consensus rating is "Hold".
| Price Target | $29.5 |
| Price Target Difference | 22% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
Stock ForecastsStock Splits
The last stock split was on Nov 17, 2020. It was a
forward
split with a ratio of 527:500.
| Last Split Date | Nov 17, 2020 |
| Split Type | forward |
| Split Ratio | 527:500 |
Scores
| Altman Z-Score | 1.91 |
| Piotroski F-Score | 8 |
